NCT03351842View on ClinicalTrials.gov

Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%

PHASE2RecruitingINTERVENTIONAL
Enrollment

460

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

September 1, 2019

Study Completion Date

September 1, 2024

Conditions
Chemotherapy, AdjuvantLung Adenocarcinoma, Stage ITreatmentHistological Type of Neoplasm
Interventions
DRUG

cis Platinum/Carboplatin, Pemetrexed Disodium

Intravenous inject Pemetrexed Disodium for Injection over 10 minutes, waiting for at least 30 minutes, then followed by cis Platinum/ Carboplatin over 2 hours

PROCEDURE

Undergo surgery

Therapeutic conventional surgery, R0 resection

Trial Locations (1)

200000

RECRUITING

Thoracic Surgery Department of Shanghai Pulmonary Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Pulmonary Hospital, Shanghai, China

OTHER